(Q31112300)

English

Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

P Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

P Parroche

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

L Chatel

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

C Barretto

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

A Beck

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

C Trépo

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

C Bain

7

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Y C Lone

8

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

G Inchauspé

9

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Anne Fournillier

10

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

397-405

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

HLA-A2 subtypes are functionally distinct in peptide binding and presentation

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Stability and CTL-activity of P40/ELA melanoma vaccine candidate

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Clinical guidelines on the management of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

The scientific challenge of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Hepatitis C virus infection: when silence is deception.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Peptide libraries for T cell epitope screening and characterization

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Cellular immune responses against hepatitis C virus: the evidence base 2002

1 reference

https://api.crossref.org/works/10.1002%2FJMV.20189

21 January 2018

Identifiers

10.1002/JMV.20189

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31112300&oldid=1956669154"